Identification of a novel splice variant of X-linked inhibitor of apoptosis-associated factor 1

Biochemical and Biophysical Research Communications

Volumn 339, Issue 4, 2006, Pages 1148-1154

  Yin, Weihong ^a   Cheepala, Satish ^a   Clifford, John L ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Apoptosis; Splice variant; XAF1; XIAP

Indexed keywords

MESSENGER RNA; NUCLEOTIDE DERIVATIVE; PROTEIN P18; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXON; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOP CODON;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA, RECOMBINANT; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; ORGAN SPECIFICITY; TISSUE DISTRIBUTION; VARIATION (GENETICS); X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 29044437621     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.11.128     Document Type: Article

References (30)

1. P.H. Krammer CD95(APO-1/Fas)-mediated apoptosis: live and let die Adv. Immunol. 71 1999 163 210
2. P.H. Krammer CD95's deadly mission in the immune system Nature 407 2000 789 795
3. M.P. Mattson Apoptosis in neurodegenerative disorders Nat. Rev. Mol. Cell Biol. 1 2000 120 129
4. J. Yuan, and B.A. Yankner Apoptosis in the nervous system Nature 407 2000 802 809
5. P. Meier, A. Finch, and G. Evan Apoptosis in development Nature 407 2000 796 801
6. D.L. Vaux, and S.J. Korsmeyer Cell death in development Cell 96 1999 245 254
7. J.A. Hickman Apoptosis and tumourigenesis Curr. Opin. Genet. Dev. 12 2002 67 72
8. S.W. Lowe, and A.W. Lin Apoptosis in cancer Carcinogenesis 21 2000 485 495
9. A.H. Wyllie Apoptosis and carcinogenesis Eur. J. Cell Biol. 73 1997 189 197
10. V. Cryns, and J. Yuan Proteases to die for Genes Dev. 12 1998 1551 1570
11. N.A. Thornberry, and Y. Lazebnik Caspases: enemies within Science 281 1998 1312 1316
12. Q.L. Deveraux, R. Takahashi, G.S. Salvesen, and J.C. Reed X-linked IAP is a direct inhibitor of cell-death proteases Nature 388 1997 300 304
13. M. Holcik, and R.G. Korneluk XIAP, the guardian angel Nat. Rev. Mol. Cell Biol. 2 2001 550 556
14. W.G. Fong, P. Liston, E. Rajcan-Separovic, M. St Jean, C. Craig, and R.G. Korneluk Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines Genomics 70 2000 113 122
15. D.W. Leaman, M. Chawla-Sarkar, K. Vyas, M. Reheman, K. Tamai, S. Toji, and E.C. Borden Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis J. Biol. Chem. 277 2002 28504 28511
16. P. Liston, W.G. Fong, N.L. Kelly, S. Toji, T. Miyazaki, D. Conte, K. Tamai, C.G. Craig, M.W. McBurney, and R.G. Korneluk Identification of XAF1 as an antagonist of XIAP anti-Caspase activity Nat. Cell Biol. 3 2001 128 133
17. M. Chawla-Sarkar, D.W. Leaman, B.S. Jacobs, and E.C. Borden IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis J. Immunol. 169 2002 847 855
18. C. Kumar-Sinha, S. Varambally, A. Sreekumar, and A.M. Chinnaiyan Molecular cross-talk between the TRAIL and interferon signaling pathways J. Biol. Chem. 277 2002 575 585
19. D.W. Leaman, M. Chawla-Sarkar, B. Jacobs, K. Vyas, Y. Sun, A. Ozdemir, T. Yi, B.R. Williams, and E.C. Borden Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2 J. Interferon Cytokine Res. 23 2003 745 756
20. K.C. Ng, E.I. Campos, M. Martinka, and G. Li XAF1 expression is significantly reduced in human melanoma J. Invest. Dermatol. 123 2004 1127 1134
21. J.L. Clifford, A.L. Sabichi, C. Zou, X. Yang, V.E. Steele, G.J. Kelloff, R. Lotan, and S.M. Lippman Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer Cancer Epidemiol. Biomarkers Prev. 10 2001 391 395
22. P. Boukamp, R.T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N.E. Fusenig Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line J. Cell Biol. 106 1988 761 771
23. W. Yin, W. Raffelsberger, and H. Gronemeyer Retinoic acid determines life span of leukemic cells by inducing antagonistic apoptosis-regulatory programs Int. J. Biochem. Cell Biol. 37 2005 1696 1708
24. Y. Matsumura, and D. Tarin Significance of CD44 gene products for cancer diagnosis and disease evaluation Lancet 340 1992 1053 1058
25. R.C. Bargou, C. Wagener, K. Bommert, M.Y. Mapara, P.T. Daniel, W. Arnold, M. Dietel, H. Guski, A. Feller, H.D. Royer, and B. Dorken Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice J. Clin. Invest. 97 1996 2651 2659
26. D.C. Porter, and K. Keyomarsi Novel splice variants of cyclin E with altered substrate specificity Nucleic Acids Res. 28 2000 E101
27. C.M. Feltes, A. Kudo, O. Blaschuk, and S.W. Byers An alternatively spliced cadherin-11 enhances human breast cancer cell invasion Cancer Res. 62 2002 6688 6697
28. R. Pio, I. Zudaire, I. Pino, Z. Castano, N. Zabalegui, S. Vicent, F. Garcia-Amigot, M.D. Odero, M.D. Lozano, J. Garcia-Foncillas, M.J. Calasanz, and L.M. Montuenga Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancer Cancer Res. 64 2004 4171 4179
29. A. Badran, A. Yoshida, K. Ishikawa, T. Goi, A. Yamaguchi, T. Ueda, and M. Inuzuka Identification of a novel splice variant of the human anti-apoptopsis gene survivin Biochem. Biophys. Res. Commun. 314 2004 902 907
30. L.H. Boise, M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thompson bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death Cell 74 1993 597 608